Low-survival cancers in which less than 50% of patients survive at least five years past diagnosis, make up nearly 20% of all cancer diagnoses – yet represent more than 40% of cancer deaths each year.
For many of these cancers there are very few or no treatment options available. For this reason, the Low Survival Cancer Alliance is advocating for significant investment to help us provide a better future for those diagnosed.
We have already had some success in 2018. The Victorian Government announced an extra $1.5 million in funding for low-survival cancer research projects. This funding contributed to Cancer Council Victoria Grants-in-Aid program with three projects beginning in 2019:
- Dr Nicholas Clemons at The Peter MacCallum Cancer Centre will lead a study to help guide treatment decision making for people with oesophageal cancer.
- Dr Catherine Granger from the University of Melbourne will evaluate whether exercise can minimise the impact of living with lung cancer.
- Dr Moritz Eissman at LaTrobe University aims to develop a new targeted treatment for gastric cancers using antibody therapies.
Cancer Council Victoria Grants-in-Aid program funds high-quality research projects into the treatment, causes, detection and prevention of all cancers, including further projects into low-survival cancers. Applications for the next round of funding are currently open, closing on 6 May, 2019.
Our own researchers in the Cancer Epidemiology Division are working on studies to discover more about the causes of low survival cancers so we can better prevent them in the future.
These projects include the EMMA Study focusing on multiple myeloma, the LEAF Study of follicular lymphoma and the CONFIRM Study investigating the causes of kidney cancer.
People with cancer have higher rates of mental illness: that’s why Cancer Council Victoria made a submission to the Royal Commission into Mental Health
Cancer Council is working to reduce the cost of cancer for Victorians. If you know someone that has been adversely affected, please encourage them to join our advoacy work to help others.
A global clinical trial led in Europe and Australia by Colebatch Fellowship recipient, Prof Kelly-Anne Phillips, has identified a treatment that helps prevent early onset of menopause in young women treated with chemotherapy for breast cancer.
Research linking some breast implants to a rare cancer, and the subsequent world-wide recall, has caused confusion at an already difficult time for people with breast cancer.